Accessing and effectively utilising biobank data efficiently remains one of the biggest hurdles for pharmaceutical companies, often delaying research, target identification and development timelines. Target identification alone can take 1-3 years due to inefficient processes for first locating data and drawing insights from it.

Lifebit’s Target ID module provides a purpose-built solution to overcome the insights challenges as it rapidly accelerates target identification and enables validation leveraging a pharma company’s data. This is paired with Lifebit’s Trusted Data Marketplace that provides pharma companies with rapid and secure access to over 250 million patients’ data across therapeutic areas including the most high-value clinico-molecular cohorts.

Learn how top pharma companies leverage these to get to data and insights faster to drive their R&D.

Join our webinar on 12 December to:

• Learn proven strategies: Discover practical approaches adopted by leaders in pharma to overcome barriers to accessing and utilizing biobank data
• Experience the established Target Identification protocol for population clinico-genomics data: See a live demonstration of how Lifebit's platform securely manages biobank data to accelerate target identification and translational research.
• Enhance your R&D to get results: Learn how to unlock the potential of biobank data to drive innovation and efficiency in your organization's research and development.

Register now!